Citigroup Inc (0R01)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 122.00 |
|---|---|
| 52-week range | 91.96 – 147.26 |
| Return, 1 month / 3 months | −9.9% / −7.7% |
| Return, 1 year / 3 years | +29.1% / +232.8% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -16.9% |
| Average daily value traded | 1.42M USD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Citigroup is a global financial services group based in New York. It provides consumer banking, including credit cards, mortgages and personal lending, alongside institutional banking services such as corporate lending, treasury and trade solutions, and investment banking. Its customers include individuals, corporations, governments and other financial institutions across many countries. Citigroup also offers wealth management and private banking to affluent clients, and its operations span retail branches, digital channels and wholesale markets around the world.
Citigroup Inc trades under the code 0R01 on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Citigroup Inc (0R01) trades on the London Exchange in UK. It last closed at USD 122.00 on 20 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,399 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.1% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.9% | ||
| From 52-week high | -15.8% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -7.0% | ||
| 12-month return, skipping the last month | 43.2% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.9% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.42M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | −9.9% |
| 3 months | −7.7% |
| 6 months | −7.0% |
| 1 year | +29.1% |
| 3 years | +232.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 132.39 / 125.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Aug 2026 | USD 0.6700 |
| 4 May 2026 | USD 0.6000 |
| 2 Feb 2026 | USD 0.6000 |
| 3 Nov 2025 | USD 0.6000 |
| 4 Aug 2025 | USD 0.6000 |
| 5 May 2025 | USD 0.5600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.